7.3 Drug Interactions & Conflicting Therapies
Key Takeaways
- Technicians should recognize major interaction and conflict patterns—drug–drug, drug–disease, drug–food/timing, and therapy conflicts such as opposing pharmacologic effects
- High-alert screens include anticoagulant + NSAID/antiplatelet stacks, serotonin combinations, QT-risk pairs, CYP-mediated interactions, and duplicate CNS depressants
- Clinical decision support alerts are clues, not automatic dismissals—document and escalate clinically important warnings to the pharmacist
- Conflicting therapies include regimens that cancel each other or create competing goals (e.g., pro-clot vs anti-clot strategies without coordination)
- Escalation with a clear description of both agents and the patient context is the correct technician response; do not override serious alerts alone
Drug Interactions & Conflicting Therapies
Quick Answer: Technicians screen for clinically important drug–drug, drug–disease, drug–food/timing interactions and for conflicting therapies that work against each other. When alerts or profile patterns suggest risk—especially bleeding, serotonin toxicity, QT prolongation, CNS depression, or major CYP interactions—document the pair and escalate to the pharmacist. Do not dismiss serious alerts on your own.
Patient Safety and Quality Assurance content on the PTCB MTM Certificate expects you to recognize interactions and conflicting therapies that should be escalated. You are not expected to memorize every CYP isoform chart, but you are expected to know the patterns that repeatedly harm patients and to act when the profile lights up.
Interaction Categories Technicians Should Name
| Category | Meaning | Technician-visible clue |
|---|---|---|
| Drug–drug | One drug alters another’s effect or level | Two active agents with a known serious interaction alert |
| Drug–disease | Drug worsens a listed condition | NSAID in documented heart failure; nonselective beta blocker in active asthma |
| Drug–food / timing | Food or schedule changes absorption or effect | Levothyroxine with breakfast calcium; MAOI diet issues flagged in history |
| Drug–alcohol / lifestyle | Substance use amplifies harm | CNS depressants + reported heavy alcohol use |
| Therapy conflict | Regimens pursue opposite goals | New prothrombotic hormone therapy on therapeutic anticoagulation without plan |
Therapy conflicts overlap with inappropriate prescribing and duplication, but the exam language often highlights opposing or incompatible strategies rather than two clones of the same class.
High-Yield Interaction Patterns for MTM Screens
Bleeding-risk stacks
Anticoagulants (warfarin, DOACs) plus NSAIDs, aspirin, dual antiplatelets, or high-dose omega-3s raise bleed risk. SSRIs plus anticoagulants can also increase bleeding. Flag every extra antiplatelet/NSAID line on an anticoagulated patient’s PMR.
Serotonergic combinations
SSRI/SNRI + MAOI (absolute crisis risk), SSRI + linezolid, SSRI + tramadol, or multiple serotonergic agents together can produce serotonin syndrome. Even if the patient “has taken them for years,” new additions deserve pharmacist review.
QT-prolonging pairs
Certain antibiotics, antipsychotics, antiarrhythmics, and other agents prolong QT. Two QT-risk drugs together, especially with electrolyte abnormalities noted in labs, warrant escalation.
CNS depressant stacking
Opioids + benzodiazepines + sedating muscle relaxants or sleep aids increase overdose and fall risk. This is both an interaction and a safety MRP.
CYP and transporter interactions (pattern recognition)
You do not need full metabolizer tables for the exam, but recognize famous pairs: strong CYP3A4 inhibitors (e.g., clarithromycin, some azoles) with sensitive substrates; rifampin inducing loss of efficacy; amiodarone with warfarin raising INR. When software flags a major CYP interaction on a narrow-therapeutic-index drug, escalate.
Potassium and renal conflict patterns
ACE inhibitor or ARB + potassium-sparing diuretic + potassium supplement is a hyperkalemia setup. NSAID + ACE inhibitor + diuretic (“triple whammy”) threatens acute kidney injury. These are drug–drug and drug–disease hybrids—flag them.
| Pattern | Example pair / stack | Primary risk |
|---|---|---|
| Bleed stack | Apixaban + naproxen | GI / major bleed |
| Serotonin | Sertraline + tramadol | Serotonin syndrome |
| QT | Azithromycin + ziprasidone | Arrhythmia |
| CNS depression | Oxycodone + alprazolam | Respiratory depression, falls |
| Efficacy loss | Rifampin + apixaban | Thrombosis from under-anticoagulation |
| Hyperkalemia | Lisinopril + spironolactone + KCl | Arrhythmia |
| Kidney injury | Ibuprofen + lisinopril + furosemide | AKI |
Conflicting Therapies Beyond Classic “Interactions”
Not every conflict shows as a yellow software banner. Watch for:
- Opposing coag strategies: Holding anticoagulation for a procedure while a prothrombotic medication continues without a bridging plan documented.
- Glycemic conflict: High-dose steroids newly started without a diabetes monitoring plan in a patient on insulin.
- Blood pressure conflict: Aggressive diuresis plus a medication known to cause fluid retention, with rising weights noted by the patient.
- Adherence conflict created by complexity: Directions that cannot be followed together (take with food / take on empty stomach for two drugs at the same prescribed clock time) without counseling adjustments.
Scenario: A TMR targets uncontrolled A1C. The profile shows insulin glargine plus a new short course of high-dose prednisone from urgent care, and the patient reports fasting glucoses “in the 300s.” This is a therapy conflict / monitoring gap. Escalate for pharmacist assessment—do not tell the patient to double insulin on your own.
Using Clinical Decision Support Without “Alert Fatigue” Shortcuts
Pharmacy systems generate many alerts. Bad habits include clicking through major warnings to clear the queue. For MTM-quality work:
- Read which drugs are implicated.
- Note severity category if shown (major/contraindicated vs minor).
- Check whether the patient is actually taking both (PMR vs profile).
- Escalate major or clinically worrying alerts to the pharmacist with patient-specific context (age, prior bleeds, recent labs).
- Document that the alert was reviewed and escalated.
Minor theoretical interactions may be handled per site protocol, but exam items about serious combinations always prefer pharmacist escalation over technician override.
Technician Script for Escalation
Effective escalation is specific: “Patient on warfarin with INR goal 2–3; new prescription for naproxen 500 mg BID for knee pain; also reports daily aspirin 81 mg. Flagging major bleed-risk interaction for pharmacist review before release.” Vague notes like “interaction?” waste time and can be missed.
Include:
- Drug names and doses
- What you think the conflict is (bleed, serotonin, QT, etc.)
- Relevant history (prior bleed, age, kidney disease)
- Whether the fill is on hold
Boundaries Again (Non-Negotiable)
| Technician may | Technician may not |
|---|---|
| Identify and describe interaction/conflict patterns | Decide the clinical significance alone for major alerts |
| Hold questionable fills per protocol | Override contraindicated alerts without pharmacist review |
| Gather timing/OTC details that complete the picture | Recommend starting grapefruit juice avoidance plans that change therapy without pharmacist involvement when a major interaction is in play |
| Support pharmacist–prescriber clarification | Tell the patient to stop a chronic anticoagulant because an NSAID was prescribed |
Interactions and conflicts are where MTM technicians prevent some of the most serious preventable harms. Pattern recognition plus disciplined escalation is the skill the exam is testing.
A patient on apixaban presents a new prescription for naproxen 500 mg twice daily. What is the technician’s best action?
Which pair best represents a serotonergic interaction pattern technicians should escalate?
Clinical decision support flags a major interaction between clarithromycin and a patient’s narrow-therapeutic-index medication. The technician is busy. What should they do?
A patient on insulin starts high-dose prednisone after urgent care, and home glucoses are newly very high. This situation is best described as: